News Roundup | Study Shows Infected Covid-19 Patients Have Effective and Possibly Long-Term Immunity

Story 1 | Study Led by Fred Hutch & Emory Investigators Shows SARS-CoV-2 Infected Patients Have Broad, Effective & Possibly Long-Term Immunity

A sophisticated team of researchers operating at Fred Hutchinson Cancer Research Center and Emory University suggest that transcending the COVID-19 pandemic necessitates what they refer to as “long-lived immunity to SARS-CoV-2.” Leading a longitudinal study involving 254 COVID-19 patients over an eight-month period, the study team observed what they referred to as “durable broad-based immune responses” in those mild-to-moderate COVID-19 patients.

Article Link | https://trialsitenews.com/study-led-by-fred-hutch-emory-investigators-shows-sars-cov-2-infected-patients-have-broad-effective-possibly-long-term-immunity/

Story 2 | Vaccination Crisis or False Alarm in Israel? 90% of COVID-19 Patients Fully Vaccinated

Israel led the pandemic as an organized, prepared, and aligned population that accepted an aggressive, methodical, and overall successful effort leading to one of the most vaccinated populations against SARS-CoV-2, the virus behind COVID-19. But with the delta variant came breakthrough infections. That is, individual...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee